As of 2024-10-13, the Intrinsic Value of ANI Pharmaceuticals Inc (ANIP) is
64.75 USD. This ANIP valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 57.14 USD, the upside of ANI Pharmaceuticals Inc is
13.30%.
The range of the Intrinsic Value is 40.43 - 160.11 USD
64.75 USD
Intrinsic Value
ANIP Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
40.43 - 160.11 |
64.75 |
13.3% |
| DCF (Growth 10y) |
45.01 - 163.56 |
69.36 |
21.4% |
| DCF (EBITDA 5y) |
37.09 - 49.37 |
41.73 |
-27.0% |
| DCF (EBITDA 10y) |
43.91 - 62.91 |
51.43 |
-10.0% |
| Fair Value |
6.41 - 6.41 |
6.41 |
-88.78% |
| P/E |
8.16 - 29.24 |
15.31 |
-73.2% |
| EV/EBITDA |
23.19 - 50.42 |
36.12 |
-36.8% |
| EPV |
36.49 - 55.19 |
45.84 |
-19.8% |
| DDM - Stable |
12.36 - 54.58 |
33.47 |
-41.4% |
| DDM - Multi |
22.19 - 77.40 |
34.63 |
-39.4% |
ANIP Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,201.65 |
| Beta |
0.51 |
| Outstanding shares (mil) |
21.03 |
| Enterprise Value (mil) |
1,246.79 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.69% |
| Cost of Debt |
9.61% |
| WACC |
8.46% |